Home LiteratureArticle Details
PMID: 24008661 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Detailed analysis of inflammatory cell infiltration in colorectal cancer.

British journal of cancer ·Vol. 109 ·No. 7 ·2013-10-01 ·Pages 1839-47

Väyrynen JP, Tuomisto A, Klintrup K, Mäkelä J, Karttunen TJ, Mäkinen MJ

Abstract

Higher-grade inflammatory infiltrate is a promising marker for better prognosis in colorectal cancer (CRC). However, the knowledge on the interrelationships between different inflammatory cells and classifications is fragmentary. We analysed the densities of eight types of inflammatory cells in a prospectively recruited group of 117 CRC patients and determined their interrelationships and contributions to Klintrup-Mäkinen (K-M) score of overall peritumoural inflammation. We characterised the inflammatory infiltrate in relation to stage and recurrences in 24-month follow-up. There were high positive correlations between the inflammatory cell densities, with the exception of mast cells and CD1a+ immature dendritic cells. High K-M score associated with high peri- and intratumoural densities of CD3+, CD8+, CD68+, CD83+, and FoxP3+ cells and neutrophils. Advanced stage associated with low K-M score, as well as low CD3+, CD8+, CD83+, and FoxP3+ cell counts, of which low K-M score, low CD3(+) T-cell count, and low FoxP3+ T-cell count were linked to higher recurrence rate. The density of CRC inflammatory infiltrate declines as stage advances. Especially, low K-M score and low T-cell counts predict higher recurrence rate. The high positive correlations between the individual inflammatory markers support the value of overall inflammatory reaction scoring.

MeSH Terms
Aged Antigens, CD/metabolism Antigens, CD1/metabolism Antigens, Differentiation, Myelomonocytic/metabolism CD3 Complex/metabolism CD8 Antigens/metabolism Colorectal Neoplasms/immunology Dendritic Cells/immunology Female Forkhead Transcription Factors/metabolism Humans Immunoglobulins/metabolism Inflammation/immunology Lymphocyte Count Male Mast Cells/immunology Membrane Glycoproteins/metabolism Neoplasm Recurrence, Local Neutrophils/immunology Prognosis T-Lymphocytes/immunology
Chemicals
Antigens, CD Antigens, CD1 Antigens, Differentiation, Myelomonocytic CD1a antigen CD3 Complex CD68 antigen, human CD8 Antigens CD83 antigen FOXP3 protein, human Forkhead Transcription Factors Immunoglobulins Membrane Glycoproteins
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Väyrynen J P
1] Department of Pathology, University of Oulu, POB 5000, 90014 Oulu, Finland [2] Oulu University Hospital and Medical Research Center Oulu, POB 21, 90029 Oulu, Finland.
Tuomisto A
Klintrup K
Mäkelä J
Karttunen T J
Mäkinen M J
References (40)
40 references, click to expand
  1. Cancer statistics, 2009.
    CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49 PMID: 19474385
  2. High frequency of tumor-infiltrating FOXP3(+) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients.
    Int J Cancer. 2010 Jun 1;126(11):2635-43 PMID: 19856313
  3. Inflammation and prognosis in colorectal cancer.
    Eur J Cancer. 2005 Nov;41(17):2645-54 PMID: 16239109
  4. Effector memory T cells, early metastasis, and survival in colorectal cancer.
    N Engl J Med. 2005 Dec 22;353(25):2654-66 PMID: 16371631
  5. Stage-dependent alterations of the serum cytokine pattern in colorectal carcinoma.
    Br J Cancer. 2012 Nov 6;107(10):1729-36 PMID: 23059742
  6. Regulatory T cells, tumour immunity and immunotherapy.
    Nat Rev Immunol. 2006 Apr;6(4):295-307 PMID: 16557261
  7. The relationships between cellular components of the peritumoural inflammatory response, clinicopathological characteristics and survival in patients with primary operable colorectal cancer.
    Br J Cancer. 2012 Jun 5;106(12):2010-5 PMID: 22596238
  8. An improved image analysis method for cell counting lends credibility to the prognostic significance of T cells in colorectal cancer.
    Virchows Arch. 2012 May;460(5):455-65 PMID: 22527018
  9. Deficient DNA mismatch repair: a common etiologic factor for colon cancer.
    Hum Mol Genet. 2001 Apr;10(7):735-40 PMID: 11257106
  10. Short-term preoperative radiotherapy interferes with the determination of pathological parameters in rectal cancer.
    J Pathol. 2002 May;197(1):20-7 PMID: 12081199
  11. Intratumoral macrophage counts correlate with tumor progression in colorectal cancer.
    J Surg Oncol. 2010 Sep 1;102(3):242-8 PMID: 20740582
  12. Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures.
    J Clin Oncol. 2008 Sep 20;26(27):4410-7 PMID: 18802153
  13. Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma.
    Cancer. 2001 Jun 15;91(12):2417-22 PMID: 11413533
  14. Prognostic value of tumour necrosis and host inflammatory responses in colorectal cancer.
    Br J Surg. 2012 Feb;99(2):287-94 PMID: 22086662
  15. Lymphocytic infiltration and survival in rectal cancer.
    J Clin Pathol. 1986 Jun;39(6):585-9 PMID: 3722412
  16. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion.
    Science. 2011 Mar 25;331(6024):1565-70 PMID: 21436444
  17. Local and distant recurrences in rectal cancer patients are predicted by the nonspecific immune response; specific immune response has only a systemic effect--a histopathological and immunohistochemical study.
    BMC Cancer. 2001;1:7 PMID: 11481031
  18. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer.
    J Clin Oncol. 2009 Jan 10;27(2):186-92 PMID: 19064967
  19. Intraepithelial effector (CD3+)/regulatory (FoxP3+) T-cell ratio predicts a clinical outcome of human colon carcinoma.
    Gastroenterology. 2009 Oct;137(4):1270-9 PMID: 19577568
  20. Hallmarks of cancer: the next generation.
    Cell. 2011 Mar 4;144(5):646-74 PMID: 21376230
  21. The role of the in situ local inflammatory response in predicting recurrence and survival in patients with primary operable colorectal cancer.
    Cancer Treat Rev. 2012 Aug;38(5):451-66 PMID: 21945823
  22. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome.
    Science. 2006 Sep 29;313(5795):1960-4 PMID: 17008531
  23. Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors.
    World J Gastroenterol. 2009 Dec 21;15(47):5898-906 PMID: 20014453
  24. Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse.
    J Clin Oncol. 2006 Dec 1;24(34):5373-80 PMID: 17135638
  25. Tumour inflammatory infiltrate predicts survival following curative resection for node-negative colorectal cancer.
    Eur J Cancer. 2009 Aug;45(12):2138-45 PMID: 19409772
  26. Epithelial-mesenchymal transition mediated tumourigenesis in the gastrointestinal tract.
    World J Gastroenterol. 2008 Jun 28;14(24):3792-7 PMID: 18609701
  27. Cancer classification using the Immunoscore: a worldwide task force.
    J Transl Med. 2012 Oct 03;10:205 PMID: 23034130
  28. Mature dendritic cells make clusters with T cells in the invasive margin of colorectal carcinoma.
    J Pathol. 2002 Jan;196(1):37-43 PMID: 11748640
  29. High macrophage infiltration along the tumor front correlates with improved survival in colon cancer.
    Clin Cancer Res. 2007 Mar 1;13(5):1472-9 PMID: 17332291
  30. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors.
    J Clin Oncol. 2002 Feb 15;20(4):1043-8 PMID: 11844828
  31. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival.
    Nat Med. 2004 Sep;10(9):942-9 PMID: 15322536
  32. Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator phenotype.
    Clin Cancer Res. 2009 Oct 15;15(20):6412-20 PMID: 19825961
  33. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes.
    Trends Immunol. 2002 Nov;23(11):549-55 PMID: 12401408
  34. Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer.
    Ann Surg. 2009 May;249(5):788-93 PMID: 19387324
  35. CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer.
    Cancer Res. 1998 Aug 15;58(16):3491-4 PMID: 9721846
  36. Serum MMP-8 levels increase in colorectal cancer and correlate with disease course and inflammatory properties of primary tumors.
    Int J Cancer. 2012 Aug 15;131(4):E463-74 PMID: 21918979
  37. The immune contexture in human tumours: impact on clinical outcome.
    Nat Rev Cancer. 2012 Mar 15;12(4):298-306 PMID: 22419253
  38. Immune infiltration in human tumors: a prognostic factor that should not be ignored.
    Oncogene. 2010 Feb 25;29(8):1093-102 PMID: 19946335
  39. Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review.
    J Pathol. 2010 Dec;222(4):350-66 PMID: 20927778
  40. Immunobiology of dendritic cells.
    Annu Rev Immunol. 2000;18:767-811 PMID: 10837075
Article Info
Journal
British journal of cancer
Abbr.
Br J Cancer
ISSN
1532-1827
Published
2013-10-01
Epub
2013-00-05
Pages
1839-47
Language
English
Region
England
NLM ID
0370635
PMCID
PMC3790164
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com